當(dāng)前位置：   首頁 > 需求大廳

陜西xxx制藥公司：主要經(jīng)營原料藥和各種劑型（包括片劑、膠囊劑、氣霧劑、免疫制劑、顆粒劑、軟膏劑、丸劑、口服液、吸入劑、注射劑、）的醫(yī)藥產(chǎn)品（包括但不限于化學(xué)原料藥、化學(xué)藥制劑、中藥材、中成藥、中藥飲片的研發(fā)、制造和銷售，擁有98個(gè)醫(yī)藥批文，60畝廠區(qū)，四條GMP認(rèn)證生產(chǎn)線，150名員工，企業(yè)正常生產(chǎn)，股權(quán)清晰，沒有債務(wù)等糾紛，老板其他產(chǎn)業(yè)資金鏈緊張，現(xiàn)欲1.8億整體轉(zhuǎn)讓，有意者請聯(lián)系13917764548，非誠勿擾。 沒需求的，中介機(jī)構(gòu)的請繞道，浪費(fèi)彼此的時(shí)間，這個(gè)年代最耗不起的就是時(shí)間，如果你只是無聊，請別打電話，非常感謝您的配合。   [更多]

標(biāo)題：化藥注射劑2.3類，臨床批件轉(zhuǎn)讓 奈維利注射液主治肩周炎、腰肌勞損、膝關(guān)節(jié)骨性關(guān)節(jié)炎、頸椎病、腰肩盤突出等腰腿病。   [更多]

https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_journal_home_pr?p_JournalID=2&p_VolumeID=42   [更多]

求購“Amoxicillin trihydrate.”《 EP9.4 》的藥典標(biāo)準(zhǔn)一份.謝謝   [更多]

標(biāo)題： 1、Am Heart J. 2000 Dec;140(6):840-7. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Lucas C1, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW. 2、An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma 3、Dapoxetine: LY 210448 4、《Analytical Methods》 , 2012 , 4 (12) :4063-4067 5、Curr Opin Allergy Clin Immunol.?2017?Apr;17(2):99-103. doi: 10.1097/ACI.0000000000000346. Asthma?guidelines: the?Global?Initiative for?Asthma?in relation to national guidelines. 6、Kalin P, Mayer JM, Etter JC. Influence of preservatives on the irritation potential of a local anaesthetic on murine cornea. Eur J Pharm Biopharm 1996; 42: 402. 7、Catalytic and Regioselective Ring Expansion of Arylcyclobutanones with Trimethylsilyldiazomethane. Ligand-Dependent Entry to β- Ketosilane or Enolsilane Adducts 8、An Expeditious and Solvent-Free Synthesis of Substituted Pyrroles Using Sulfated Anatase-Titania as a Solid Acid Catalyst 9、Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials 10、Synlett, 1998 , # 9 p. 1022 - 1024 Evelyn 11、Organic and Biomolecular Chemistry, 2016 , vol. 14, # 13 p. 3459 - 3468 12、SCOPE (Study of Cognition and Prognosis in the Elderly) and ACCESS ( evaluation of acute candesartan cilexetil in stroke survivors) Trials Expert Opinion on Pharmacotherapy 13、STROKE REDUCTION WITH CANDESARTAN BASED THERAPY IN THE SCOPE STUDY - OUTCOMES IN PATIENTS BY BASELINE CHARACTERISTICS 14、Study on COgnition and Prognosis in the Elderly (SCOPE) 要求：將符合標(biāo)題的PDF文件打包上傳，根據(jù)投稿時(shí)間定稿，先到先得   [更多]

求購“Amoxicillin Capsules”《 JP17(英) 》的藥典標(biāo)準(zhǔn)一份.謝謝   [更多]

求購“Amoxicillin Capsules”《 BP2017 》的藥典標(biāo)準(zhǔn)一份.謝謝   [更多]

求購“USP Monographs: Olmesartan Medoxomil Tablets”《 USP41-NF36 》的藥典標(biāo)準(zhǔn)一份.   [更多]

求購“Formulated Preparations: Specific Monographs-Olmesartan Tablets”《 BP2018 》的藥典標(biāo)準(zhǔn)一份.   [更多]

標(biāo)題：Dexamethasone Sodium Phosphate”《 BP2017 》的藥典標(biāo)準(zhǔn)一份 詳細(xì)要求： 需求名稱：Dexamethasone Sodium Phosphate”《 BP2017 》的藥典標(biāo)準(zhǔn)一份 要求時(shí)間：請?jiān)?月8日之前 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]